Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 415

1.

Whole genome sequence of Vibrio cholerae directly from dried spotted filter paper.

Bénard AHM, Guenou E, Fookes M, Ateudjieu J, Kasambara W, Siever M, Rebaudet S, Boncy J, Adrien P, Piarroux R, Sack DA, Thomson N, Debes AK.

PLoS Negl Trop Dis. 2019 May 30;13(5):e0007330. doi: 10.1371/journal.pntd.0007330. eCollection 2019 May.

2.

Feasibility of a Comprehensive Targeted Cholera Intervention in The Kathmandu Valley, Nepal.

Roskosky M, Acharya B, Shakya G, Karki K, Sekine K, Bajracharya D, von Seidlein L, Devaux I, Lopez AL, Deen J, Sack DA.

Am J Trop Med Hyg. 2019 May;100(5):1088-1097. doi: 10.4269/ajtmh.18-0863.

3.

Enhancing immune responses to oral vaccines: still an enigma.

Sack DA.

Lancet Infect Dis. 2019 Feb;19(2):122-123. doi: 10.1016/S1473-3099(18)30662-5. Epub 2019 Jan 30. No abstract available.

4.

Scaling up zinc treatment of childhood diarrhoea in Bangladesh: theoretical and practical considerations guiding the SUZY Project.

Larson CP, Koehlmoos TP, Sack DA; Scaling Up of Zinc for Young Children (SUZY) Project Team.

Health Policy Plan. 2018 Dec 1;33(10):1145. doi: 10.1093/heapol/czy090. No abstract available.

PMID:
30608589
5.

Vibrio cholerae Transmits Through Water Among the Household Contacts of Cholera Patients in Cholera Endemic Coastal Villages of Bangladesh, 2015-2016 (CHoBI7 Trial).

Rahman Z, Rahman MA, Rashid MU, Monira S, Johura FT, Mustafiz M, Bhuyian SI, Zohura F, Parvin T, Hasan K, Saif-Ur-Rahman KM, Islam NN, Sack DA, George CM, Alam M.

Front Public Health. 2018 Aug 30;6:238. doi: 10.3389/fpubh.2018.00238. eCollection 2018.

6.

Environmental Surveillance of Vibrio cholerae O1/O139 in the Five African Great Lakes and Other Major Surface Water Sources in Uganda.

Bwire G, Debes AK, Orach CG, Kagirita A, Ram M, Komakech H, Voeglein JB, Buyinza AW, Obala T, Brooks WA, Sack DA.

Front Microbiol. 2018 Aug 3;9:1560. doi: 10.3389/fmicb.2018.01560. eCollection 2018.

7.

Protection from killed oral cholera vaccine continues for 4 years.

Sack DA, Ali M.

Lancet Glob Health. 2018 Sep;6(9):e946-e947. doi: 10.1016/S2214-109X(18)30311-5. No abstract available.

8.

A prospective cohort study comparing household contact and water Vibrio cholerae isolates in households of cholera patients in rural Bangladesh.

George CM, Hasan K, Monira S, Rahman Z, Saif-Ur-Rahman KM, Rashid MU, Zohura F, Parvin T, Islam Bhuyian MS, Mahmud MT, Li S, Perin J, Morgan C, Mustafiz M, Sack RB, Sack DA, Stine OC, Alam M.

PLoS Negl Trop Dis. 2018 Jul 27;12(7):e0006641. doi: 10.1371/journal.pntd.0006641. eCollection 2018 Jul.

10.

Molecular characterization of Vibrio cholerae responsible for cholera epidemics in Uganda by PCR, MLVA and WGS.

Bwire G, Sack DA, Almeida M, Li S, Voeglein JB, Debes AK, Kagirita A, Buyinza AW, Orach CG, Stine OC.

PLoS Negl Trop Dis. 2018 Jun 4;12(6):e0006492. doi: 10.1371/journal.pntd.0006492. eCollection 2018 Jun.

11.

Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development.

Chakraborty S, Randall A, Vickers TJ, Molina D, Harro CD, DeNearing B, Brubaker J, Sack DA, Bourgeois AL, Felgner PL, Liang X, Mani S, Wenzel H, Townsend RR, Gilmore PE, Darsley MJ, Rasko DA, Fleckenstein JM.

J Infect Dis. 2018 Sep 22;218(9):1436-1446. doi: 10.1093/infdis/jiy312.

PMID:
29800314
12.

Enterotoxigenic Escherichia coli-blood group A interactions intensify diarrheal severity.

Kumar P, Kuhlmann FM, Chakraborty S, Bourgeois AL, Foulke-Abel J, Tumala B, Vickers TJ, Sack DA, DeNearing B, Harro CD, Wright WS, Gildersleeve JC, Ciorba MA, Santhanam S, Porter CK, Gutierrez RL, Prouty MG, Riddle MS, Polino A, Sheikh A, Donowitz M, Fleckenstein JM.

J Clin Invest. 2018 Aug 1;128(8):3298-3311. doi: 10.1172/JCI97659. Epub 2018 Jun 25.

13.

Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers.

Chakraborty S, Harro C, DeNearing B, Brubaker J, Connor S, Maier N, Dally L, Flores J, Bourgeois AL, Walker R, Sack DA.

PLoS Negl Trop Dis. 2018 Apr 27;12(4):e0006442. doi: 10.1371/journal.pntd.0006442. eCollection 2018 Apr.

14.

Biofilms Comprise a Component of the Annual Cycle of Vibrio cholerae in the Bay of Bengal Estuary.

Sultana M, Nusrin S, Hasan NA, Sadique A, Ahmed KU, Islam A, Hossain A, Longini I, Nizam A, Huq A, Siddique AK, Sack DA, Sack RB, Colwell RR, Alam M.

MBio. 2018 Apr 17;9(2). pii: e00483-18. doi: 10.1128/mBio.00483-18.

15.

Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses.

Iyer AS, Azman AS, Bouhenia M, Deng LO, Anderson CP, Graves M, Kováč P, Xu P, Ryan ET, Harris JB, Sack DA, Luquero FJ, Leung DT.

PLoS Negl Trop Dis. 2018 Jan 29;12(1):e0006196. doi: 10.1371/journal.pntd.0006196. eCollection 2018 Jan.

16.

Identifying cholera "hotspots" in Uganda: An analysis of cholera surveillance data from 2011 to 2016.

Bwire G, Ali M, Sack DA, Nakinsige A, Naigaga M, Debes AK, Ngwa MC, Brooks WA, Garimoi Orach C.

PLoS Negl Trop Dis. 2017 Dec 28;11(12):e0006118. doi: 10.1371/journal.pntd.0006118. eCollection 2017 Dec.

17.

High Prevalence of Shigella or Enteroinvasive Escherichia coli Carriage among Residents of an Internally Displaced Persons Camp in South Sudan.

Bliss J, Bouhenia M, Hale P, Couturier BA, Iyer AS, Rumunu J, Martin S, Wamala JF, Abubakar A, Sack DA, Luquero FJ, Couturier MR, Azman AS, Leung DT.

Am J Trop Med Hyg. 2018 Feb;98(2):595-597. doi: 10.4269/ajtmh.17-0339. Epub 2017 Nov 30.

18.

Abundance and Dynamics of Anopheles (Diptera: Culicidae) Larvae in a Malaria Endemic Area of Bangladesh.

Alam MS, Al-Amin HM, Elahi R, Chakma S, Kafi MAH, Khan WA, Haque R, Sack DA, Sullivan DJ Jr, Norris DE.

J Med Entomol. 2018 Feb 28;55(2):382-391. doi: 10.1093/jme/tjx196.

PMID:
29182782
19.

Genetic relatedness of Vibrio cholerae isolates within and between households during outbreaks in Dhaka, Bangladesh.

George CM, Rashid M, Almeida M, Saif-Ur-Rahman KM, Monira S, Bhuyian MSI, Hasan K, Mahmud TT, Li S, Brubaker J, Perin J, Rahman Z, Mustafiz M, Sack DA, Sack RB, Alam M, Stine OC.

BMC Genomics. 2017 Nov 25;18(1):903. doi: 10.1186/s12864-017-4254-9.

20.

Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine: A Systematic Review and Metaanalysis.

Lopez AL, Deen J, Azman AS, Luquero FJ, Kanungo S, Dutta S, von Seidlein L, Sack DA.

Clin Infect Dis. 2018 Jun 1;66(12):1960-1971. doi: 10.1093/cid/cix1039.

21.

Alkaline peptone water enrichment with a dipstick test to quickly detect and monitor cholera outbreaks.

Bwire G, Orach CG, Abdallah D, Debes AK, Kagirita A, Ram M, Sack DA.

BMC Infect Dis. 2017 Nov 21;17(1):726. doi: 10.1186/s12879-017-2824-8.

22.

Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial.

Rimmer JE, Harro C, Sack DA, Talaat KR, Gutierrez RL, DeNearing B, Brubaker J, Laird RM, Poly F, Maue AC, Jaep K, Alcala A, Mochalova Y, Gariepy CL, Chakraborty S, Guerry P, Tribble DR, Porter CK, Riddle MS.

Clin Infect Dis. 2018 Apr 17;66(9):1435-1441. doi: 10.1093/cid/cix1014.

PMID:
29145631
23.

Health seeking behaviour among suspected cases of cholera in Cameroonian health districts in Lake Chad basin.

Yakum MN, Ateudjieu J, Guenou E, Walter EA, Ram M, Debes AK, Njimbia AC, Nafack SS, Sack DA.

BMC Res Notes. 2017 Aug 30;10(1):433. doi: 10.1186/s13104-017-2756-9.

24.

Identification of burden hotspots and risk factors for cholera in India: An observational study.

Ali M, Sen Gupta S, Arora N, Khasnobis P, Venkatesh S, Sur D, Nair GB, Sack DA, Ganguly NK.

PLoS One. 2017 Aug 24;12(8):e0183100. doi: 10.1371/journal.pone.0183100. eCollection 2017.

25.

Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis.

Bi Q, Ferreras E, Pezzoli L, Legros D, Ivers LC, Date K, Qadri F, Digilio L, Sack DA, Ali M, Lessler J, Luquero FJ, Azman AS; Oral Cholera Vaccine Working Group of The Global Task Force on Cholera Control.

Lancet Infect Dis. 2017 Oct;17(10):1080-1088. doi: 10.1016/S1473-3099(17)30359-6. Epub 2017 Jul 17. Review.

26.

Risk Factors for Household Transmission of Vibrio cholerae in Dhaka, Bangladesh (CHoBI7 Trial).

Burrowes V, Perin J, Monira S, Sack DA, Rashid MU, Mahamud T, Rahman Z, Mustafiz M, Bhuyian SI, Begum F, Zohura F, Biswas S, Parvin T, Hasan T, Zhang X, Sack BR, Saif-Ur-Rahman KM, Alam M, George CM.

Am J Trop Med Hyg. 2017 Jun;96(6):1382-1387. doi: 10.4269/ajtmh.16-0871.

27.

Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial.

Zaman K, Sack DA, Neuzil KM, Yunus M, Moulton LH, Sugimoto JD, Fleming JA, Hossain I, Arifeen SE, Azim T, Rahman M, Lewis KDC, Feller AJ, Qadri F, Halloran ME, Cravioto A, Victor JC.

PLoS Med. 2017 Apr 18;14(4):e1002282. doi: 10.1371/journal.pmed.1002282. eCollection 2017 Apr.

28.

Integration of water, sanitation and hygiene intervention delivery at health facilities with a reactive ring vaccination programme to reduce cholera.

George CM, Sack DA.

Int J Epidemiol. 2017 Dec 1;46(6):2093-2094. doi: 10.1093/ije/dyx025. No abstract available.

29.

Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study.

Ali M, Nelson A, Luquero FJ, Azman AS, Debes AK, M'bang'ombe MM, Seyama L, Kachale E, Zuze K, Malichi D, Zulu F, Msyamboza KP, Kabuluzi S, Sack DA.

Lancet Infect Dis. 2017 May;17(5):538-544. doi: 10.1016/S1473-3099(16)30523-0. Epub 2017 Feb 2.

30.

Psychosocial Factors Mediating the Effect of the CHoBI7 Intervention on Handwashing With Soap: A Randomized Controlled Trial.

George CM, Biswas S, Jung D, Perin J, Parvin T, Monira S, Saif-Ur-Rahman KM, Rashid MU, Bhuyian SI, Thomas ED, Dreibelbis R, Begum F, Zohura F, Zhang X, Sack DA, Alam M, Sack RB, Leontsini E, Winch PJ.

Health Educ Behav. 2017 Aug;44(4):613-625. doi: 10.1177/1090198116683141. Epub 2017 Jan 10.

PMID:
28071141
31.

Cholera Rapid Test with Enrichment Step Has Diagnostic Performance Equivalent to Culture.

Ontweka LN, Deng LO, Rauzier J, Debes AK, Tadesse F, Parker LA, Wamala JF, Bior BK, Lasuba M, But AB, Grandesso F, Jamet C, Cohuet S, Ciglenecki I, Serafini M, Sack DA, Quilici ML, Azman AS, Luquero FJ, Page AL.

PLoS One. 2016 Dec 19;11(12):e0168257. doi: 10.1371/journal.pone.0168257. eCollection 2016.

32.

The opportunities & challenges in delivering oral cholera vaccines.

Deen J, Sack DA.

Indian J Med Res. 2016 Aug;144(2):149-150. doi: 10.4103/0971-5916.194997. No abstract available.

33.

Factors Associated with Fatal Outcomes Following Cholera-Like Syndrome in Far North Region of Cameroon: A Community-Based Survey.

Djouma FN, Ateudjieu J, Ram M, Debes AK, Sack DA.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1287-1291. Epub 2016 Oct 17.

34.

Ensuring access to oral cholera vaccine to those who need them most.

Luquero FJ, Ballard A, Sack DA.

Vaccine. 2017 Jan 11;35(3):411. doi: 10.1016/j.vaccine.2016.11.074. No abstract available.

PMID:
27916414
35.

Transmission of Infectious Vibrio cholerae through Drinking Water among the Household Contacts of Cholera Patients (CHoBI7 Trial).

Rafique R, Rashid MU, Monira S, Rahman Z, Mahmud MT, Mustafiz M, Saif-Ur-Rahman KM, Johura FT, Islam S, Parvin T, Bhuyian MS, Sharif MB, Rahman SR, Sack DA, Sack RB, George CM, Alam M.

Front Microbiol. 2016 Oct 18;7:1635. eCollection 2016.

36.

Cholera cases cluster in time and space in Matlab, Bangladesh: implications for targeted preventive interventions.

Debes AK, Ali M, Azman AS, Yunus M, Sack DA.

Int J Epidemiol. 2016 Dec 1;45(6):2134-2139. doi: 10.1093/ije/dyw267.

PMID:
27789673
37.

Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South Sudan.

Iyer AS, Bouhenia M, Rumunu J, Abubakar A, Gruninger RJ, Pita J, Lino RL, Deng LL, Wamala JF, Ryan ET, Martin S, Legros D, Lessler J, Sack DA, Luquero FJ, Leung DT, Azman AS.

Sci Rep. 2016 Oct 24;6:35742. doi: 10.1038/srep35742.

38.

Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study.

Azman AS, Parker LA, Rumunu J, Tadesse F, Grandesso F, Deng LL, Lino RL, Bior BK, Lasuba M, Page AL, Ontweka L, Llosa AE, Cohuet S, Pezzoli L, Sodjinou DV, Abubakar A, Debes AK, Mpairwe AM, Wamala JF, Jamet C, Lessler J, Sack DA, Quilici ML, Ciglenecki I, Luquero FJ.

Lancet Glob Health. 2016 Nov;4(11):e856-e863. doi: 10.1016/S2214-109X(16)30211-X.

39.

Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial.

Ali M, Debes AK, Luquero FJ, Kim DR, Park JY, Digilio L, Manna B, Kanungo S, Dutta S, Sur D, Bhattacharya SK, Sack DA.

PLoS Med. 2016 Sep 13;13(9):e1002120. doi: 10.1371/journal.pmed.1002120. eCollection 2016 Sep.

40.

Subclinical Plasmodium falciparum infections act as year-round reservoir for malaria in the hypoendemic Chittagong Hill districts of Bangladesh.

Shannon KL, Khan WA, Sack DA, Alam MS, Ahmed S, Prue CS, Khyang J, Ram M, Haq MZ, Akter J, Glass GE, Shields TM, Galagan SR, Nyunt MM, Sullivan DJ Jr.

Int J Infect Dis. 2016 Aug;49:161-9. doi: 10.1016/j.ijid.2016.06.019. Epub 2016 Jun 24.

41.

Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment.

Pop M, Paulson JN, Chakraborty S, Astrovskaya I, Lindsay BR, Li S, Bravo HC, Harro C, Parkhill J, Walker AW, Walker RI, Sack DA, Stine OC.

BMC Genomics. 2016 Jun 8;17:440. doi: 10.1186/s12864-016-2777-0.

42.
43.

SEASON OF DELTAMETHRIN APPLICATION AFFECTS FLEA AND PLAGUE CONTROL IN WHITE-TAILED PRAIRIE DOG (CYNOMYS LEUCURUS) COLONIES, COLORADO, USA.

Tripp DW, Streich SP, Sack DA, Martin DJ, Griffin KA, Miller MW.

J Wildl Dis. 2016 Jul;52(3):553-61. doi: 10.7589/2015-10-290. Epub 2016 May 19.

PMID:
27195680
44.

Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014.

Azman AS, Rumunu J, Abubakar A, West H, Ciglenecki I, Helderman T, Wamala JF, Vázquez Ode L, Perea W, Sack DA, Legros D, Martin S, Lessler J, Luquero FJ.

Emerg Infect Dis. 2016 Jun;22(6):1067-70. doi: 10.3201/eid2206.151592.

45.

Comparison of inferred relatedness based on multilocus variable-number tandem-repeat analysis and whole genome sequencing of Vibrio cholerae O1.

Rashid MU, Almeida M, Azman AS, Lindsay BR, Sack DA, Colwell RR, Huq A, Morris JG Jr, Alam M, Stine OC.

FEMS Microbiol Lett. 2016 Jun;363(12). pii: fnw116. doi: 10.1093/femsle/fnw116. Epub 2016 Apr 28.

46.

Correction: Evaluation in Cameroon of a Novel, Simplified Methodology to Assist Molecular Microbiological Analysis of V. cholerae in Resource-Limited Settings.

Debes AK, Ateudjieu J, Guenou E, Lopez AL, Bugayong MP, Retiban PJ, Garrine M, Mandomando I, Li S, Stine OC, Sack DA.

PLoS Negl Trop Dis. 2016 Mar 21;10(3):e0004573. doi: 10.1371/journal.pntd.0004573. eCollection 2016 Mar. No abstract available.

47.

Correction: The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study.

Azman AS, Luquero FJ, Ciglenecki I, Grais RF, Sack DA, Lessler J.

PLoS Med. 2016 Mar 11;13(3):e1001989. doi: 10.1371/journal.pmed.1001989. eCollection 2016 Mar. No abstract available.

48.

Correction: Evaluation in Cameroon of a Novel, Simplified Methodology to Assist Molecular Microbiological Analysis of V. cholerae in Resource-Limited Settings.

Debes AK, Ateudjieu J, Guenou E, Lopez AL, Bugayong MP, Retiban PJ, Garrine M, Mandomando I, Li S, Stine OC, Sack DA.

PLoS Negl Trop Dis. 2016 Mar 8;10(3):e0004537. doi: 10.1371/journal.pntd.0004537. eCollection 2016 Mar. No abstract available.

49.

An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli.

Porter CK, Riddle MS, Alcala AN, Sack DA, Harro C, Chakraborty S, Gutierrez RL, Savarino SJ, Darsley M, McKenzie R, DeNearing B, Steinsland H, Tribble DR, Bourgeois AL.

PLoS One. 2016 Mar 3;11(3):e0149358. doi: 10.1371/journal.pone.0149358. eCollection 2016.

50.

Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.

Chakraborty S, Harro C, DeNearing B, Bream J, Bauers N, Dally L, Flores J, Van de Verg L, Sack DA, Walker R.

Clin Vaccine Immunol. 2016 Apr 4;23(4):315-25. doi: 10.1128/CVI.00608-15. Print 2016 Apr.

Supplemental Content

Support Center